Darren Bondar, president and CEO of Inner Spirit Holdings (CSE:ISH), believes when it comes to signing deals with license holders for retail locations, companies still need to answer to investors and find proper returns for these transactions.

Bondar spoke with the Investing News Network (INN) during the MJBizConINT’L event in Toronto. At the show he also participated in a panel discussion on lessons learned from the first year of adult-use legalization in Canada from the perspective of retailers.

The executive told INN he is hopeful the Ontario market will move forward with an open system for retail stores. During the panel, the cannabis executive said Ontario could “easily hold 1,000 stores without looking like the pot capital of the world.”

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

Ontario has proven to be one of the most complex markets for marijuana retailers. The province elected to introduce a lottery system to grant options to earn a store license. This year two lotteries have taken place, with the second round expected to result in new stores in October.

A variety of publicly traded marijuana companies have pursued deals with lottery winners. These deals grant companies a chance to participate in the opening and maintenance of actual stores.

In August, Inner Spirit, through its retail brand Spiritleaf, announced deals with two lottery winners for stores in the East and Greater Toronto Area regions of Ontario, as designated by the Alcohol and Gaming Commission of Ontario.

“These lottery winners were seeking a strong partner to work with, so we are very pleased Spiritleaf has been selected to help them establish and operate their stores,” Bondar said in a statement.

Bondar told INN that dealing with slow regulations has been a difficult process for fellow retail operator companies, with many having to retain leases on planned shops for months.

In a previous interview with INN, Matthew Pallotta, equity research analyst at Echelon Wealth Partners covering the multi-state operator market in the US, said in his estimation the lack of retail access to consumers, due to a slow roll out, is one of, if not the biggest, detriments to the Canadian market since adult-use legalization.

Bondar hopes the opening of the Ontario market will pave the way to easing this issue across the country.

Watch the interview above to hear the rest of Bondar’s comments from the cannabis event.

Don’t forget to look for the rest of our coverage of MJBizConINT’L, with exclusive interviews and more insights from the show. You can also follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less